Support Centre
25 October 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

New application
Updating record

governing board
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Usefulness of a three-step guideline to reduce length of hospital stay for patients with community-acquired pneumonia: a randomised controlled trial
DOI 10.1186/ISRCTN17875607
ClinicalTrials.gov identifier
EudraCT number
Public title Usefulness of a three-step guideline to reduce length of hospital stay for patients with community-acquired pneumonia: a randomised controlled trial
Scientific title
Acronym N/A
Serial number at source FIS 040139
Study hypothesis The implementation of a three-step guideline would be effective and safe in reducing length of stay for hospitalized patients with community-acquired pneumonia
Lay summary Not provided at time of registration
Ethics approval Approved by the Ethics Committee of the University of Bellvitge (Comite Etic d´Investigació de l´Hospital Universitari de Bellvitge), July 2004, reference number: 05/FIS-008
Study design Randomised controlled trial
Countries of recruitment Spain
Disease/condition/study domain Community-acquired pneumonia
Participants - inclusion criteria Immunocompetent adults (aged >18 years) who have received a diagnosis of community-acquired pneumonia in the emergency department and are admitted to the hospital
Participants - exclusion criteria 1. Severe immunosuppression (neutropenia, transplantation, human immunodeficiency virus [HIV] infection)
2. Imminent death
3. Intensive care unit (ICU) admission
4. Shock
5. Complicated pleural effusion
6. Aspiration pneumonia
7. Social problem (homelessness)
8. Not able to drink and eat
9. Absence of written informed consent
Anticipated start date 24/04/2006
Anticipated end date 31/12/2007
Status of trial Completed
Patient information material
Target number of participants 376
Interventions Patients will be randomly assigned to one of two groups:
1. Use of a three-step guideline, including early mobilization, and pre-defined criteria for switch antibiotic therapy and hospital discharge
2. Control group (conventional management)
Primary outcome measure(s) Length of hospital stay
Secondary outcome measure(s) 1. Time to switch
2. Readmission (<30 days)
3. Overall mortality (<30 days)
4. Satisfaction with care
Sources of funding Investigation of Sanitary Funding (Fondo de Investivación Sanitaria) IDIBELL
Trial website
Publications 1. 2012 abstract in http://www.ncbi.nlm.nih.gov/pubmed/22732747
Contact name Dr  Jordi  Carratala
  Address Infectious Disease Service

Hospital Universitari de Bellvitge

Feixa Llarga s/n

  City/town Barcelona
  Zip/Postcode 08907
  Country Spain
  Tel +34 (0)93 260 76 25
  Fax +34 (0)93 260 76 37
  Email jcarratala@wanadoo.es
Sponsor Spanish National Health Service (Fondo de Investigación Sanitaria)
  Address Sinesio Delgado 4
  City/town Madrid
  Zip/Postcode 28029
  Country Spain
Date applied 18/04/2006
Last edited 02/08/2012
Date ISRCTN assigned 17/05/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.